AiBiotics
Changwon
About AiBiotics
AiBiotics develops an all-in-one RT-PCR for POCT diagnosis that can detect infectious diseases like Coronavirus at site in real-time. In the RT-PCR product, a multi-diagnostic cartridge allows for the diagnosis of multiple diseases with only a single sample. One cartridge can be used for molecular diagnosis and immunochemical diagnosis at the same time. By working with domestic general hospitals and primary hospitals, the company is building a comprehensive healthcare platform by conducting microbiome analysis and healthcare clinics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jul 2022)
- Website: aibiotics.kr
- Phone: +82 031.695.6058
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/aibiotics-2903001 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.